Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1973 1
1978 1
1980 1
1981 1
1982 3
1984 1
1986 1
1990 2
1991 6
1992 5
1993 5
1994 4
1995 4
1996 1
1997 8
1998 6
1999 6
2000 4
2001 5
2002 7
2003 11
2004 13
2005 8
2006 6
2007 9
2008 6
2009 6
2010 8
2011 10
2012 14
2013 13
2014 24
2015 40
2016 38
2017 28
2018 22
2019 22
2020 34
2021 46
2022 27
2023 33
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

472 results

Results by year

Filters applied: . Clear all
Page 1
Virological characteristics of the SARS-CoV-2 JN.1 variant.
Kaku Y, Okumura K, Padilla-Blanco M, Kosugi Y, Uriu K, Hinay AA Jr, Chen L, Plianchaisuk A, Kobiyama K, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium; Zahradnik J, Ito J, Sato K. Kaku Y, et al. Lancet Infect Dis. 2024 Feb;24(2):e82. doi: 10.1016/S1473-3099(23)00813-7. Epub 2024 Jan 3. Lancet Infect Dis. 2024. PMID: 38184005 No abstract available.
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami… See abstract for full author list ➔ Ota T, et al. Among authors: kaku y. Nat Genet. 2004 Jan;36(1):40-5. doi: 10.1038/ng1285. Epub 2003 Dec 21. Nat Genet. 2004. PMID: 14702039
Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants.
Kaku Y, Yo MS, Tolentino JE, Uriu K, Okumura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Lancet Infect Dis. 2024 Aug;24(8):e482-e483. doi: 10.1016/S1473-3099(24)00415-8. Epub 2024 Jun 27. Lancet Infect Dis. 2024. PMID: 38945150 No abstract available.
Malignant blue melanoma.
Kaku Y, Fouchardière A. Kaku Y, et al. Clin Dermatol. 2024 Sep 9:S0738-081X(24)00171-8. doi: 10.1016/j.clindermatol.2024.09.002. Online ahead of print. Clin Dermatol. 2024. PMID: 39260463
[Nipah virus infection].
Kaku Y. Kaku Y. Uirusu. 2004 Dec;54(2):237-42. doi: 10.2222/jsv.54.237. Uirusu. 2004. PMID: 15745162 Free article. Review. Japanese.
Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant.
Kaku Y, Uriu K, Okumura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Lancet Infect Dis. 2024 Oct;24(10):e609. doi: 10.1016/S1473-3099(24)00505-X. Epub 2024 Aug 16. Lancet Infect Dis. 2024. PMID: 39159637 No abstract available.
Virological characteristics of the SARS-CoV-2 KP.2 variant.
Kaku Y, Uriu K, Kosugi Y, Okumura K, Yamasoba D, Uwamino Y, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Lancet Infect Dis. 2024 Jul;24(7):e416. doi: 10.1016/S1473-3099(24)00298-6. Epub 2024 May 20. Lancet Infect Dis. 2024. PMID: 38782005 No abstract available.
472 results